Hamid Dolat Abadi, Ali Parsa, John Stelzer, Adam Anz, M H Ebrahimzadeh, Farshid Bagheri, Amirshahriar Ariamanesh, Neda Mirzaei
OBJECTIVES: Based on WHO data, as of June 2022, there were 532.2 million confirmed COVID-19 cases globally. In the initial phase of the COVID -19 pandemic, patients experiencing critical illness marked by severe respiratory distress were commonly subjected to corticosteroid treatment. Regrettably, the administration of exogenous corticosteroids stands as the prevailing cause of ONFH. In the current narrative review, we aim to evaluate if active screening should be utilized to diagnose post-COVID-19 ONFH in its early stages...
2023: Archives of Bone and Joint Surgery